RXi Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Biotechnology | RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

25,660

0.59%

07/31/2018

Fidelity Spartan Extended Market Index Fund

9,194

0.21%

07/31/2018

iShares Core S&P Total US Stock Market ETF

403

0.01%

09/06/2018

-4,892

06/30/2017

View Profile

Address	257 Simarano Drive Marlborough Massachusetts 01752 United States
Employees	-
Website	http://www.rxipharma.com
Updated	09/14/2018
RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.